We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Stephen Hauser

Stephen L. Hauser MD

Director, UCSF Weill Institute for Neurosciences; Professor, Department of Neurology, University of California, San Francisco, San Francisco, California

Stephen L. Hauser, MD, directs the UCSF Weill Institute for Neurosciences, linking the clinical and basic neurosciences at UCSF to accelerate research against neurologic diseases. Dr. Hauser’s research has advanced our understanding of the genetics, immunology, and treatment of multiple sclerosis (MS). His work led to the development of B cell therapies for MS patients, representing a powerful new approach for relapsing forms of the disease and the first therapy of proven value for progressive MS.

He is a member of the National Academy of Medicine and a fellow of the American Academy of Arts and Sciences and the American Academy of Physicians. He is an editor of the textbook Harrison’s Principles of Internal Medicine. Previously chairman of the Department of Neurology at UCSF for 25 years, he has also served as President of the American Neurological Association, President of the Medical Staff at UCSF, Chair of the Research Advisory Committee for the VA, and editor-in-chief of Annals of Neurology. He also served the Obama administration as a member of the Presidential Commission for the Study of Bioethical Issues charged with advising the President on issues that may emerge from advances in biomedicine and related areas of science and technology.

Disclosures

Stephen L. Hauser, MD serves on the board of directors for Neurona and on scientific advisory boards for Alector, Annexon, Bionure, and Molecular Stethoscope. He has also received travel reimbursement and writing assistance from F Hoffmann-La Roche Ltd and Novartis AG for CD20-related meetings and presentations.

Recent Contributions to PracticeUpdate:

  1. Ublituximab Use in Patients With Relapsing MS